RESEARCH TRIANGLE PARK, NORTH CAROLINA, UNITED STATES, September 9, 2019 /EINPresswire.com/ — Global Lyme Diagnostics has been providing state of the art Lyme Disease testing to 48 states for
nearly two years now. As of this week, the company now has received regulatory clearance to offer its
testing to patients in Pennsylvania, leaving New York as the only state where the testing is not available.
Lyme Disease was first discovered in Lyme, Connecticut and the majority of Lyme Disease cases every
year fall in the northeast meaning the newly available GLD Lyme Screen will be a huge benefit for
potential Lyme patients living in Pennsylvania.
“We are happy to have gone through the process for our clearances in Pennsylvania and are excited to
be able to offer an affordable and effective test for Lyme Disease and various coinfections to the patients
in the state. Given Pennsylvania’s location, there are bound to be thousands of patients that we will now
be able to help in their struggle with diagnosing Lyme Disease and coinfections,” Mickey Ramchandani,
CEO and Founder of Global Lyme Diagnostics.
Physicians that would like to learn more about Global Lyme Diagnostics can contact Dustin Starnes at
Note: The GLD Test is not yet available for NY residents. More information about GLD, including the
science behind the new test and the GLD team is available at the website at https://glymedx.com.
Global Lyme Diagnostics
email us here
Source: EIN Presswire